Published in Curr Oncol on February 01, 2007
Long-term survival in patients with metastatic melanoma treated with DTIC or temozolomide. Oncologist (2010) 0.92
Clinical practice guidelines and consensus statements in oncology--an assessment of their methodological quality. PLoS One (2014) 0.88
Update on benefit of immunotherapy and targeted therapy in melanoma: the changing landscape. Cancer Manag Res (2014) 0.81
Evolving Concepts: Immunity in Oncology from Targets to Treatments. J Oncol (2015) 0.81
Comparison of vascular leak syndrome in mice treated with IL21 or IL2. Comp Med (2013) 0.80
Reevaluating the concept of treating experimental tumors with a mixed bacterial vaccine: Coley's Toxin. Clin Dev Immunol (2012) 0.80
Tailoring the Treatment of Melanoma: Implications for Personalized Medicine. Yale J Biol Med (2015) 0.75
High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. J Clin Oncol (1999) 10.86
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol (2000) 9.70
The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol (1995) 6.08
Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol (1999) 5.95
Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response. Ann Surg (1998) 4.35
High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival update. Cancer J Sci Am (2000) 4.19
Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. Ann Surg (1989) 3.58
Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma. J Clin Oncol (2002) 2.26
Progress of clinical oncology guidelines development using the Practice Guidelines Development Cycle: the role of practitioner feedback. J Clin Oncol (1998) 1.97
Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer. J Natl Cancer Inst (1993) 1.91
Interleukin-2 therapy in patients with metastatic malignant melanoma: a phase II study. J Clin Oncol (1990) 1.17
Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanoma. J Clin Oncol (1993) 1.16
Phase II study of intermittent continuous infusion of low-dose recombinant interleukin-2 in advanced melanoma and renal cell cancer. Ann Oncol (1994) 1.10
Phase II study of intravenous bolus recombinant interleukin-2 in advanced malignant melanoma: Southwest Oncology Group study. J Natl Cancer Inst (1991) 0.89
Evaluation of interleukin-2 administered by continuous infusion in patients with metastatic melanoma. Cancer (1996) 0.87
Recombinant interleukin-2 (rIL-2) given intrasplenically and intravenously for advanced malignant melanoma. A phase I and II study. Br J Cancer (1989) 0.87
IL-2 phase II trial in metastatic melanoma: analysis of clinical and immunological parameters. Biotechnol Ther (1992) 0.82
The health-related quality-of-life impact of histamine dihydrochloride plus interleukin-2 compared with interleukin-2 alone in patients with metastatic melanoma. Support Care Cancer (2003) 0.82
Immunotherapy of metastatic melanoma with interleukin-2. Mt Sinai J Med (1992) 0.80
Bolus high dose interleukin-2 for the treatment of malignant melanoma. Isr Med Assoc J (2001) 0.78
CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry (1986) 6.14
Kin I kinesins are microtubule-destabilizing enzymes. Cell (1999) 6.07
How children and adolescents spend time across the world: work, play, and developmental opportunities. Psychol Bull (1999) 5.50
A mesoscale phytoplankton bloom in the polar Southern Ocean stimulated by iron fertilization. Nature (2000) 4.36
The human Arp2/3 complex is composed of evolutionarily conserved subunits and is localized to cellular regions of dynamic actin filament assembly. J Cell Biol (1997) 4.34
Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc Natl Acad Sci U S A (1995) 3.28
Favorable infertility outcomes following anti-tubercular treatment prescribed on the sole basis of a positive polymerase chain reaction test for endometrial tuberculosis. Hum Reprod (2012) 2.76
Hematopoietic growth factors signal through the formation of reactive oxygen species. Blood (1999) 2.43
Acute spinal cord injury, part I: pathophysiologic mechanisms. Clin Neuropharmacol (2001) 2.14
Improved endothelial function with metformin in type 2 diabetes mellitus. J Am Coll Cardiol (2001) 2.10
Aromatase inhibitors in the adjuvant setting: bringing the gold to a standard? Cancer Treat Rev (2004) 2.05
The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells. J Biol Chem (2000) 1.98
Morphological variants of plasma cell tumours. Histopathology (2004) 1.89
The surgical margin in soft-tissue sarcoma. J Bone Joint Surg Am (1989) 1.86
XCTK2: a kinesin-related protein that promotes mitotic spindle assembly in Xenopus laevis egg extracts. J Cell Biol (1997) 1.71
Patterns of ophthalmological complaints presenting to a dedicated ophthalmic Accident & Emergency department: inappropriate use and patients' perspective. Emerg Med J (2008) 1.67
HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur J Immunol (2000) 1.64
Wellness programs: a review of the evidence. CMAJ (1998) 1.64
A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women. Breast Cancer Res Treat (2009) 1.63
Adjuvant interferon therapy for patients at high risk for recurrent melanoma: an updated systematic review and practice guideline. Clin Oncol (R Coll Radiol) (2012) 1.62
Estimates of the lifetime costs of breast cancer treatment in Canada. Eur J Cancer (2000) 1.61
Adult paratesticular sarcomas: a review of 21 cases. J Urol (1991) 1.59
The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes. Clin Genet (2010) 1.58
Female genital tuberculosis: early diagnosis by laparoscopy and endometrial polymerase chain reaction. Int J Tuberc Lung Dis (2010) 1.55
Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm (2003) 1.53
Targeting triple-negative breast cancer: optimising therapeutic outcomes. Ann Oncol (2012) 1.49
Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571. Oncogene (2000) 1.47
Physical education programs and exercise-induced asthma. Individualized gym programs allow asthmatic youngsters to participate with great benefit. Clin Pediatr (Phila) (1976) 1.45
Systematic chemotherapy for inoperable, locally advanced, recurrent, or metastatic uterine leiomyosarcoma: a systematic review. Clin Oncol (R Coll Radiol) (2013) 1.45
Vanadium and diabetes. Mol Cell Biochem (1998) 1.44
Assessment of intervention outcome in the absence of baseline data: 'reconstruction' of condom use time trends using retrospective analysis of survey data. Sex Transm Infect (2010) 1.44
Antimicrobial resistance pattern and in-vitro activity of azithromycin in Salmonella isolates [corrected]. Indian J Med Microbiol (2013) 1.42
Pulse oximetry in scleroderma patients: concerns. Acta Anaesthesiol Scand (2008) 1.40
Saddle nose deformity in a patient with Crohn's disease. J Laryngol Otol (2005) 1.40
Identification and control of nosocomial adenovirus keratoconjunctivitis in an ophthalmic department. Br J Ophthalmol (2008) 1.39
Phase II study of oral menogaril as first line chemotherapy for advanced breast cancer: a National Cancer Institute of Canada Clinical Trials Group study. Ann Oncol (1992) 1.39
Risk factors for microbial keratitis with contemporary contact lenses: a case-control study. Ophthalmology (2008) 1.36
Miltefosine as an effective choice in the treatment of post-kala-azar dermal leishmaniasis. Br J Dermatol (2011) 1.34
Distinct spatial and temporal expression patterns of K+ channel mRNAs from different subfamilies. J Neurosci (1992) 1.34
Precursors of CD3+CD4+CD8+ cells in the human thymus are defined by expression of CD34. Delineation of early events in human thymic development. J Exp Med (1993) 1.32
Antifungal activity of anthraquinone derivatives from Rheum emodi. J Ethnopharmacol (2000) 1.32
Outcome and prognostic factors in soft tissue sarcoma in the adult. Int J Radiat Oncol Biol Phys (1993) 1.26
Osteoarthritis. J Assoc Physicians India (2005) 1.26
Clonal analysis of differential lymphokine production in peptide and superantigen induced T cell anergy. Int Immunol (1991) 1.24
Functionally distinct subsets of human gamma/delta T cells. Eur J Immunol (1991) 1.21
Differential regulation of leptin transport by the choroid plexus and blood-brain barrier and high affinity transport systems for entry into hypothalamus and across the blood-cerebrospinal fluid barrier. Endocrinology (2000) 1.21
Cardiac management during adjuvant trastuzumab therapy: recommendations of the Canadian Trastuzumab Working Group. Curr Oncol (2008) 1.20
Surface expression of HLA-C antigen by human extravillous trophoblast. Placenta (2000) 1.19
Quality of life in women with urinary tract infections: is benign disease a misnomer? J Am Board Fam Pract (2000) 1.18
Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individuals. Proc Natl Acad Sci U S A (1998) 1.17
Isolated total ruptures of the anterior cruciate ligament--a clinical study with long-term follow-up of 7 years. Scand J Med Sci Sports (1999) 1.16
Managing pain and comorbid depression: A public health challenge. Semin Clin Neuropsychiatry (1999) 1.15
Recognition of trophoblast HLA class I molecules by decidual NK cell receptors--a review. Placenta (2000) 1.15
An in vivo investigation of the structures responsible for corneal haze after photorefractive keratectomy and their effect on visual function. Ophthalmology (1996) 1.14
Temozolomide for the treatment of metastatic melanoma. Curr Oncol (2007) 1.13
Induction of reparative dentine formation in monkeys by recombinant human osteogenic protein-1. Arch Oral Biol (1993) 1.12
Bone morphogenetic protein-7 enhances dendritic growth and receptivity to innervation in cultured hippocampal neurons. Eur J Neurosci (2000) 1.11
Utility of adjuvant systemic therapy in melanoma. Ann Oncol (2009) 1.10
Screening for undetected mental disorders in high utilizers of primary care services. J Gen Intern Med (1999) 1.09
Welding related occupational eye injuries: a narrative analysis. Inj Prev (2005) 1.08
Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study. Eur J Pharm Biopharm (2003) 1.08
Small molecules and targeted therapies in distant metastatic disease. Ann Oncol (2009) 1.08
Flow cytometric analysis of Th1 and Th2 cytokines in PBMCs as a parameter of immunological dysfunction in patients of superficial transitional cell carcinoma of bladder. Cancer Immunol Immunother (2005) 1.08
Differential signaling after beta1 integrin ligation is mediated through binding of CRKL to p120(CBL) and p110(HEF1). J Biol Chem (1997) 1.07
mTOR inhibitors in the management of hormone receptor-positive breast cancer: the latest evidence and future directions. Ann Oncol (2012) 1.06
Dissociation between exertional symptoms and circulatory function in patients with heart failure. Circulation (1995) 1.06
Environmental exposure to lead and its correlation with biochemical indices in children. Sci Total Environ (2005) 1.04
Dependence on chlormethiazole and effects of its withdrawal. Lancet (1979) 1.04
Multidrug-resistant Salmonella typhi in India. Lancet (1999) 1.03
SHIP1, an SH2 domain containing polyinositol-5-phosphatase, regulates migration through two critical tyrosine residues and forms a novel signaling complex with DOK1 and CRKL. J Biol Chem (2000) 1.03
Budd-Chiari syndrome: our experience of 71 patients. J Gastroenterol Hepatol (2000) 1.03
Human uterine lymphocytes. Hum Reprod Update (1999) 1.02
Efflux of human and mouse amyloid beta proteins 1-40 and 1-42 from brain: impairment in a mouse model of Alzheimer's disease. Neuroscience (2003) 1.02
Cytokine expression pattern in the genital tract of Chlamydia trachomatis positive infertile women - implication for T-cell responses. Clin Exp Immunol (2004) 1.01
CD2/LFA-3 or LFA-1/ICAM-1 but not CD28/B7 interactions can augment cytotoxicity by virus-specific CD8+ cytotoxic T lymphocytes. Eur J Immunol (1993) 1.01
Matters of the heart: cardiac toxicity of adjuvant systemic therapy for early-stage breast cancer. Curr Oncol (2008) 1.00
EGF and TGF-alpha are potent chemoattractants for endothelial cells and EGF-like peptides are present at sites of tissue regeneration. J Cell Physiol (1989) 1.00
The STK2 gene, which encodes a putative Ser/Thr protein kinase, is required for high-affinity spermidine transport in Saccharomyces cerevisiae. Mol Cell Biol (1997) 1.00
Steel factor induces tyrosine phosphorylation of CRKL and binding of CRKL to a complex containing c-kit, phosphatidylinositol 3-kinase, and p120(CBL). J Biol Chem (1997) 0.99
Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer. Clin Genet (1999) 0.99
Insulin action in the vasculature: physiology and pathophysiology. J Vasc Res (2001) 0.99
Corneal optical aberrations induced by photorefractive keratectomy. J Refract Surg (1997) 0.99
Serological survey of antibodies to Toxoplasma gondii in sheep, cattle, and buffaloes in Punjab, India. J Parasitol (2008) 0.98
The role of the 5-HT3 antagonists ondansetron and dolasetron in the control of delayed onset nausea and vomiting in patients receiving moderately emetogenic chemotherapy. Ann Oncol (1997) 0.98
Is bone marrow examination in small-cell lung cancer really necessary? Ann Intern Med (1986) 0.97
Psychological and genetic counseling implications for adolescent daughters of mothers with breast cancer. Clin Genet (2005) 0.97
Cost effectiveness of TAC versus FAC in adjuvant treatment of node-positive breast cancer. Curr Oncol (2010) 0.96
Prevalence of tuberculosis, hepatitis B, hepatitis C and syphilis co-infections among HIV/AIDS patients. Indian J Med Microbiol (2008) 0.96
Drug resistance and neurotransmitter receptors of nematodes: recent studies on the mode of action of levamisole. Parasitology (2005) 0.95
Resolution of calcific band keratopathy after lowering elevated serum calcium in a patient with sarcoidosis. Br J Ophthalmol (1995) 0.95
Surgical margins and handling of soft-tissue sarcoma in extremities: a clinical practice guideline. Curr Oncol (2013) 0.95
The time-course of the induction of reparative dentine formation in monkeys by recombinant human osteogenic protein-1. Arch Oral Biol (1994) 0.94